Bengaluru, March 6 -- The shares of the pharmaceuticals company specializing in developing, manufacturing, and marketing a wide range of pharmaceuticals jumped upto 7 percent upon receiving approval from the USFDA to manufacture Dasatinib tablets in various strengths (20 mg to 140 mg).

Price action

With a market capitalization of Rs. 92,246.50 Crores on Thursday, the shares of Zydus Lifesciences Ltd jumped upto 6.8 percent after making a high of Rs. 947.95 compared to its previous closing price of Rs. 887.55.

What Happened

Zydus Lifesciences engaged in developing, manufacturing, and marketing a wide range of pharmaceuticals has received final approval from the USFDA to manufacture Dasatinib Tablets in various strengths (20 mg to 140 m...